FibroDynamx

Biotechnology Research • • 1-10 Employees

Company overview

Headquarters	XX
Website	fibrodynamx.com
NAICS	541714
Founded	2024
Employees	1-10

Key Contact at FibroDynamx

Nicole Rosin

Founder/CEO

FibroDynamx Email Formats

FibroDynamx uses 1 email format. The most common is {first name} (e.g., john@fibrodynamx.com), used 100% of the time.

Format	Example	Percentage
{first name}	john@fibrodynamx.com	100%

About FibroDynamx

FibroDynamx is a drug discovery company developing therapies that promote tissue regeneration, without scarring. The platform is based on our Regenerative Blueprint, which combines proprietary data from our reindeer model with human wound healing data. FibroDynamx's first product (FD-001, a protein-based drug) prevents scar formation, and improves skin regeneration 10-fold in animal models of skin injury.

FibroDynamx revenue & valuation

Annual revenue	$85,555
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$273,776
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

FibroDynamx has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

FibroDynamx has never raised funding before.

Frequently asked questions

FibroDynamx is located in XX.

FibroDynamx was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

FibroDynamx has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at FibroDynamx

Nicole Rosin

Founder/CEO

4.8

40,000 users